A phase I/II study of RAD001 [everolimus] in advanced hepatocellular carcinoma
Phase of Trial: Phase I/II
Latest Information Update: 09 Feb 2017
At a glance
- Drugs Everolimus (Primary)
- Indications Liver cancer
- Focus Adverse reactions; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 09 Feb 2017 Last checked against ClinicalTrials.gov record.
- 17 Mar 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.